Provectus Biopharmaceuticals Inc (OP: PVCT )

0.1199 +0.0062 (+5.45%)
Streaming Delayed Price Updated: 3:59 PM EST, Nov 22, 2024 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
July 01, 2013
Form 424B3
Source: SEC/Edgar
May 09, 2013
Form DEF 14A
Source: SEC/Edgar
April 29, 2013
Form PRE 14A
Source: SEC/Edgar
April 18, 2013
Form 8-K
Source: SEC/Edgar
April 17, 2013
Form 424B3
Source: SEC/Edgar
April 15, 2013
Form EFFECT
Source: SEC/Edgar
April 14, 2013
Form EFFECT
Source: SEC/Edgar
April 08, 2013
Form EFFECT
Source: SEC/Edgar
April 08, 2013
Form POS AM
Source: SEC/Edgar
April 07, 2013
Form POS AM
Source: SEC/Edgar
April 07, 2013
Form S-1
Source: SEC/Edgar
April 07, 2013
Form D
Source: SEC/Edgar
March 07, 2013
Form 8-K
Source: SEC/Edgar
February 27, 2013
Form SC 13G/A
Source: SEC/Edgar
February 11, 2013
Form 8-K
Source: SEC/Edgar
November 22, 2012
Form D
Source: SEC/Edgar
November 18, 2012
Form FWP
Source: SEC/Edgar
October 22, 2012
Form 8-K
Source: SEC/Edgar
October 16, 2012
Form 424B5
Source: SEC/Edgar
September 03, 2012
Form D
Source: SEC/Edgar
August 02, 2012
Form EFFECT
Source: SEC/Edgar
July 19, 2012
Form 8-K
Source: SEC/Edgar
July 01, 2012
Form S-3
Source: SEC/Edgar
July 01, 2012
Form 8-K
Source: SEC/Edgar
May 13, 2012
Form DEF 14A
Source: SEC/Edgar
April 29, 2012
Form D
Source: SEC/Edgar
March 21, 2012
Form SC 13G/A
Source: SEC/Edgar
February 13, 2012
Form 8-K
Source: SEC/Edgar
December 19, 2011
Form 8-K
Source: SEC/Edgar
September 18, 2011
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.